HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LCB 2183 inhibits the inflammation associated with oxazolone-induced contact sensitivity.

Abstract
LCB 2183, an anti-allergic and potential anti-asthma compound, has been investigated for its ability to inhibit contact sensitivity in the mouse. The delayed response to epicutaneous hapten challenge in this model is a classical T-cell-mediated inflammatory reaction which is dependent on an early initiation phase. Both the early and late components of oxazolone-induced contact sensitivity were inhibited by oral administration of LCB 2183 in a dose-dependent manner. The drug appears to act on the efferent limb of the response since administration before hapten challenge was effective, while administration before the initial sensitization was not. LCB 2183 acts early in the cascade of events leading to inflammation, since the initiation phase of the response was inhibited; nonetheless, an effect of the drug on the late acting inflammatory cells cannot be ruled out. In comparison with oral prednisolone, which was also able to inhibit both the early and late components of the response, LCB 2183 was less active. Sodium cromoglycate and nedocromil sodium, which are poorly absorbed from the gastrointestinal tract, were tested by intraperitoneal administration. Neither of these agents significantly altered the delayed response and only nedocromil sodium had a limited inhibitory effect on the early initiation phase. Thus, in this model, LCB 2183 demonstrated more anti-inflammatory potential and resembled prednisolone more closely than either nedocromil sodium or sodium cromoglycate. The possible relevance of these effects in relation to the inflammation which characterizes human asthma is considered.
AuthorsN Murray, N Zoerkler, T Brown, Y Bonhomme
JournalInternational journal of immunopharmacology (Int J Immunopharmacol) Vol. 16 Issue 8 Pg. 675-83 (Aug 1994) ISSN: 0192-0561 [Print] England
PMID7989136 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Pterins
  • Nedocromil
  • Oxazolone
  • LCB 2183
  • Prednisolone
  • Cromolyn Sodium
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, pharmacology, therapeutic use)
  • Cromolyn Sodium (pharmacology, therapeutic use)
  • Dermatitis, Allergic Contact (drug therapy, etiology)
  • Drug Administration Schedule
  • Drug Eruptions (drug therapy, etiology)
  • Drug Evaluation, Preclinical
  • Ear
  • Edema (prevention & control)
  • Female
  • Mice
  • Mice, Inbred CBA
  • Nedocromil (pharmacology, therapeutic use)
  • Oxazolone (toxicity)
  • Prednisolone (pharmacology, therapeutic use)
  • Pterins
  • T-Lymphocyte Subsets (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: